Latest Market News

Cambium Bio has updated its placement, raising A$2.17 million to fund late-stage clinical trials for its lead ophthalmology product, Elate Ocular®. The capital raise reflects strong investor interest and strategic backing.

Optiscan Imaging Ltd has launched a fully underwritten $17.75 million entitlement offer to fund clinical trials and regulatory clearances for its medical devices, marking a pivotal step in its transition to a commercial medical device manufacturer.

betr Entertainment Limited has increased its takeover offer for PointsBet shares to 4.375 betr shares per PointsBet share, valuing each at $1.40 and surpassing MIXI’s cash bid. The company also expanded its selective buy-back pool to $90 million, signaling confidence in its acquisition strategy.

Invion Limited posted a $8.8 million loss for FY25, marking a 56.5% increase, while advancing clinical trials and securing fresh capital. The biotech faces a going concern warning amid ongoing development and funding challenges.

Ava Group Limited reported solid FY25 results with 5% revenue growth to $31.7 million and a turnaround to positive EBITDA of $2.1 million, underpinned by strong demand for its Aura Ai-X security solutions and a robust $88 million sales pipeline.

Ava Risk Group reported a 5% revenue increase to $31.7 million in FY2025, achieving a significant turnaround to $2.1 million underlying EBITDA. The company expanded its Aura Ai-X technology into new sectors and regions despite some order delays.

Provaris Energy has raised $1 million through a share placement to accelerate its hydrogen and CO2 storage and transport commercialisation programs, targeting new markets in Asia and Europe.

AVA Risk Group reported a 5% increase in revenue to $31.6 million for FY2025 but saw losses widen by 24% and EBITDA fall by 34%, with no dividend declared.

Ainsworth Game Technology has formally cancelled its planned Scheme Meeting following the termination of its scheme transaction with Novomatic AG, while the Independent Board Committee continues to recommend acceptance of Novomatic’s $1 per share takeover bid.

Pengana International Equities has acknowledged breaching ASX disclosure rules by sharing details of a new private credit strategy with media before official announcement, prompting a policy overhaul.

Stealth Group Holdings has reported a record-breaking 2025 financial year, with sales climbing 27.6% and net profit more than doubling. The company is accelerating its growth strategy, aiming to more than double sales by 2028.

Stealth Group Holdings has reported a landmark FY25 with sales soaring 27.6% to $145.1 million and net profit more than doubling. The company’s strategic investments and operational discipline set the stage for ambitious growth targets through FY28.